| Metric | Q2 2026 | Q2 2025 |
|---|---|---|
| Profit before tax | -97.2 | -125.9 |
| Net income | -97.2 | -126.5 |
| EPS (diluted, $ a share) | $-0.47 | $-0.73 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
10-Q filed with the SEC, NASDAQ: IMVT. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Immunovant, Inc.: key numbers
- Share price
- $33.28Close, Nov 16
- Market cap
- $6.89B
- Shares outstanding
- 206.95MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Biological Products, (No Diagnostic Substances)SIC 2836
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Immunovant, Inc.
All →Immunovant Insider Atul Pande Sells $108K of Stock
Atul Pande sold 3,000 shares of Immunovant, Inc. at $36.00 a share, worth $108K in total on Nov 11, 2026. Shares held after the trade: 116,731 (-2.5%).
- Value
- $108K
- Shares
- 3,000
- Price
- $36.00
- Holding change
- -2.5%
- Trade date
- Nov 11, 2026
Immunovant Financial Results
Immunovant reported financial results for its fiscal second quarter ended September 30, 2026, and announced positive topline data from a potentially registrational trial of IMVT-1402 in rheumatoid arthritis. The company ended the quarter with $722.3 million in cash and cash equivalents, which it expects will fund operations into 2028.
- Term
- Q2 2026
Immunovant CFO Tiago Girao Sells $188K of Stock
Tiago Girao, CFO, sold 6,606 shares of Immunovant, Inc. at $28.50 a share, worth $188K in total on Oct 28, 2026. Shares held after the trade: 234,192 (-2.7%).
- Value
- $188K
- Shares
- 6,606
- Price
- $28.50
- Role
- CFO
- Holding change
- -2.7%
- Trade date
- Oct 28, 2026
Immunovant CTO Jay S. Stout Sells $122K of Stock
Jay S. Stout, CTO, sold 3,809 shares of Immunovant, Inc. at $32.06 a share, worth $122K in total on Oct 7, 2026. Shares held after the trade: 201,532 (-0.8%).
- Value
- $122K
- Shares
- 3,809
- Average price
- $32.06
- Role
- CTO
- Holding change
- -0.8%
- Trade date
- Oct 7, 2026
Immunovant CLO Tuyl Christopher Van Sells $42.5K of Stock
Tuyl Christopher Van, CLO, sold 1,327 shares of Immunovant, Inc. at $32.06 a share, worth $42.5K in total on Oct 7, 2026. Shares held after the trade: 175,218 (-0.8%).
- Value
- $42.5K
- Shares
- 1,327
- Price
- $32.06
- Role
- CLO
- Holding change
- -0.8%
- Trade date
- Oct 7, 2026
Immunovant COO Melanie Gloria Sells $71.8K of Stock
Melanie Gloria, COO, sold 2,241 shares of Immunovant, Inc. at $32.06 a share, worth $71.8K in total on Oct 7, 2026. Shares held after the trade: 217,060 (-1.0%).
- Value
- $71.8K
- Shares
- 2,241
- Price
- $32.06
- Role
- COO
- Holding change
- -1.0%
- Trade date
- Oct 7, 2026